Weight loss drugs are now excluded from mandatory coverage. ... Brooks-LaSure says it would be about 1% of the money spent during that time on prescription drugs for Medicare and 2% on Medicaid.

It is not covered for weight loss by Medicare, but the FDA in early 2024 approved its use for obese patients who also have cardiovascular disease. The list cost for Wegovy is about $1,349 per ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...